<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Freudenberg-Hua Y</submitter><funding>National Institute on Aging</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>COVID-19 has been associated with an increased risk of incident dementia (post-COVID dementia). Establishing additional risk markers may help identify at-risk individuals and guide clinical decision-making.&lt;h4>Methods&lt;/h4>We investigated pre-COVID psychotropic medication use (exposure) and 1-year incidence of dementia (outcome) in 1,755 patients (≥65 years) hospitalized with COVID-19. Logistic regression models were used to examine the association, adjusting for demographic and clinical variables. For further confirmation, we applied the Least Absolute Shrinkage and Selection Operator (LASSO) regression and a machine learning (Random Forest) algorithm.&lt;h4>Results&lt;/h4>One-year incidence rate of post-COVID dementia was 12.7% (&lt;i>N&lt;/i> = 223). Pre-COVID psychotropic medicat</pubmed_abstract><journal>Frontiers in medicine</journal><pagination>841326</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8972194</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Psychotropic Medication Use Is Associated With Greater 1-Year Incidence of Dementia After COVID-19 Hospitalization.</pubmed_title><pmcid>PMC8972194</pmcid><pubmed_authors>Marziliano A</pubmed_authors><pubmed_authors>Kane JM</pubmed_authors><pubmed_authors>Greenwald B</pubmed_authors><pubmed_authors>Carney M</pubmed_authors><pubmed_authors>Qiu M</pubmed_authors><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Koppel J</pubmed_authors><pubmed_authors>Freudenberg-Hua Y</pubmed_authors><pubmed_authors>Burns E</pubmed_authors><pubmed_authors>Sinvani L</pubmed_authors><pubmed_authors>Makhnevich A</pubmed_authors><pubmed_authors>Diefenbach M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Psychotropic Medication Use Is Associated With Greater 1-Year Incidence of Dementia After COVID-19 Hospitalization.</name><description>&lt;h4>Background&lt;/h4>COVID-19 has been associated with an increased risk of incident dementia (post-COVID dementia). Establishing additional risk markers may help identify at-risk individuals and guide clinical decision-making.&lt;h4>Methods&lt;/h4>We investigated pre-COVID psychotropic medication use (exposure) and 1-year incidence of dementia (outcome) in 1,755 patients (≥65 years) hospitalized with COVID-19. Logistic regression models were used to examine the association, adjusting for demographic and clinical variables. For further confirmation, we applied the Least Absolute Shrinkage and Selection Operator (LASSO) regression and a machine learning (Random Forest) algorithm.&lt;h4>Results&lt;/h4>One-year incidence rate of post-COVID dementia was 12.7% (&lt;i>N&lt;/i> = 223). Pre-COVID psychotropic medicat</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-06-01T01:33:38.8Z</modification><creation>2024-11-14T02:05:50.424Z</creation></dates><accession>S-EPMC8972194</accession><cross_references><pubmed>35372430</pubmed><doi>10.3389/fmed.2022.841326</doi></cross_references></HashMap>